Soft and hard commitment devices to increase HIV testing

How to cite

Sterck, Olivier; Kerwin, Jason; Derksen, Laura; Reynoso, Natalia Ordaz. 2019. "Soft and hard commitment devices to increase HIV testing." AEA RCT Registry. AEARCTR-0004295. https://doi.org/10.1257/rct.4295-3.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Olivier Sterck* , Jason Kerwin , Laura Derksen , Natalia Ordaz Reynoso

* Primary investigator

Registry ID
AEARCTR-0004295
DOI
https://doi.org/10.1257/rct.4295-3.0
First registered
Last updated
Status
Completed
Trial dates
2019-06-21 – 2020-12-31
Countries
Malawi (Zomba town)
JEL codes
I1, O1, H4
Registry record
http://www.socialscienceregistry.org/trials/4295

Abstract

Our goal is to study innovative ways to overcome the challenge of getting HIV-positive people into the treatment pipeline. Despite the availability of free, life-saving treatment, nearly one million people died of AIDS in 2017. This is largely driven by low HIV testing rates: a quarter of those living with HIV do not know their status (WHO 2017). In Africa this problem is worse for men, in part because pregnant women are routinely tested and treated for HIV. We will investigate whether a soft commitment device (a scheduled appointment) and a hard commitment device (a small money transfer conditional on HIV testing) can increase HIV testing among men in Zomba Town, Malawi.

Intervention

We will investigate whether a soft commitment device (a scheduled appointment) and a hard commitment device (small money transfer conditional on HIV testing) can increase HIV testing among men in Zomba Town, Malawi.

We believe that procrastination (a tendency to delay) is a barrier to HIV testing for many people. We will assess the impact of two interventions that aim at reducing procrastination and thereby overcome the problem of continuously putting off HIV testing.

(1) A soft commitment device: selected participants will be offered scheduled appointments to test for HIV. Appointments are devices for mental and social commitment.

(2) A hard commitment device: selected participants will be invited to invest in a mechanism that conditions a small transfer of money on testing for HIV.

Experimental design

We use a factorial design.

Design details

Randomization method
The randomization process will be predefined in a .csv downloaded on survey tablets, and hence reproducible. Randomization will be at the individual level without stratification. Each study participant will be automatically allocated to a treatment arm based on their Study ID which is composed of their enumerator ID, day of the study, and number of the survey. For example, the first enumerator’s first respondent on the first day of the study will have Study ID 010101.
Randomization unit
Individual
Clusters
No cluster
Observations
1200 individuals
Arms
For the soft commitment device intervention (appointments), we will have 600 participants in the treatment group and 600 participants in the control group. For the hard commitment device intervention (conditional money transfer) , we will have 600 participants in the treatment group and 600 participants in the control group for the intent-to-treat analysis. When calculating the average treatment effect on the treated, the sample size will depend on the take-up rate of the hard commitment device: denoting this take-up rate r, 600*r participants will be in the treatment group and 600*r participants will be in the control group for this analysis.
Primary outcomes
Our primary outcome variable is a testing dummy collected at clinics when participants redeem their voucher. The testing dummy will be equal to 1 for participants who redeemed their voucher and then agreed to get tested, and equal to 0 otherwise.
Secondary outcomes
We will consider two secondary outcomes collected at clinics: (1) A "tested HIV+ dummy": a dummy variable equal to 1 for participants who redeemed their voucher and tested HIV+, and equal to 0 otherwise. (2) An "ART dummy": a dummy variable equal to 1 for participants who redeemed their voucher and agreed to initiate ARV treatment after testing HIV+, and equal to 0 otherwise. These outcomes are considered as secondary not because they are uninteresting (quite the contrary) but rather because power will most likely be insufficient to detect any effect.

Papers from this trial

  1. Derksen, Laura, Jason Kerwin, Natalia Ordaz Reynoso, and Olivier Sterck. (2023). Healthcare Appointments as Commitment Devices. Working Paper. https://www.jasonkerwin.com/Papers/Appointments/DKOS_Appointments_Latest.pdf

Cited by

No citation data available for this registration yet.

Keywords